209 results
Page 2 of 11
424B3
7w92opw4go7w2u34hn9s
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
s1klkgr5zt 9hzba
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
8-K
EX-10.1
esh rs7rm7ltv3efu
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
UPLOAD
v90c14hf4 84
6 Apr 23
Letter from SEC
12:00am
S-4
j69b svok
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
5nr30vfa2sw
25 Oct 22
Adaptimmune Enhances its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK
8:10am
8-K
EX-10.1
472ed 9hsu8
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am